Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venture Capital
Biotech
Aspen adds $115M series C to grow cell therapy ambitions
The raise will power Aspen’s phase 1/2 study of ANPD001, a regenerative cell therapy for Parkinson's disease.
Darren Incorvaia
Nov 20, 2025 7:02am
Fierce Biotech Fundraising Tracker: Aspen, Solve Tx & more
Nov 20, 2025 5:00am
Jefferies London conference earns reputation as 'JPM for Europe'
Nov 18, 2025 10:00am
ADC biotech raises $120M to seek best-in-class formula
Nov 17, 2025 8:00am
VC Sofinnova ropes in €650M despite 'volatile' environment
Nov 16, 2025 7:01pm
European VC Medicxi closes €500M biotech fund
Nov 14, 2025 3:00am
